Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tumor-selective CTLA-4 antagonists

Tumor-selective CTLA-4 antagonists

US Patent 11279752 · Granted Mar 22, 2022

Estimated economic value: $7,141,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Activatable masked anti-CTLA4 binding proteins2025
Anti-CD6 antibody-growth factor complex for treating autoimmune diseases2025
Tumor-specific cleavable linkers2025
Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy2024
Multi-specific ligand binders2024
CTLA4-binding protein peptide-linker masks2024
CTLA4-binding protein peptide-linker masks2024
CTLA4-binding protein peptide-linker masks2024
Mechanically interlocking complexes2024
Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy2023
Development of masked therapeutic antibodies to limit off-target effects2022
Development of masked therapeutic antibodies to limit off-target effects2022